Literature DB >> 24346159

The promise of sonodynamic therapy.

Matthew Trendowski1.   

Abstract

Sonodynamic therapy is a potential cancer treatment modality that has been gaining support due to its effectiveness in both in vitro and in vivo studies. The therapeutic method combines ultrasonic irradiation with drugs known as sonosensitizers that amplify its ability to inflict preferential damage on malignant cells. This is based on the idea that ultrasonic waves have the ability to exhibit profound physical and chemical changes on cellular structure. The mechanisms by which ultrasound (US) disrupts cellular functioning can be further amplified when sonosensitizers are applied. Combining multiple sonosensitizers with US to create a substantial synergistic effect could be an effective method for destroying tumorigenic growths, while decreasing the likelihood of drug resistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24346159     DOI: 10.1007/s10555-013-9461-5

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  35 in total

Review 1.  A review of low-intensity ultrasound for cancer therapy.

Authors:  Andrew K W Wood; Chandra M Sehgal
Journal:  Ultrasound Med Biol       Date:  2015-04       Impact factor: 2.998

Review 2.  Ultrasound-based triggered drug delivery to tumors.

Authors:  Ankit Jain; Ankita Tiwari; Amit Verma; Sanjay K Jain
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

3.  Tumor ablation using low-intensity ultrasound and sound excitable drug.

Authors:  Ching-Hsuan Tung; Myung Shin Han; Young Kim; Jianjun Qi; Brian E O'Neill
Journal:  J Control Release       Date:  2017-05-10       Impact factor: 9.776

Review 4.  Current status and future perspective of sonodynamic therapy for cancer.

Authors:  Atsushi Sofuni; Takao Itoi
Journal:  J Med Ultrason (2001)       Date:  2022-10-12       Impact factor: 1.878

Review 5.  Ultrasound-Responsive Nanocarriers in Cancer Treatment: A Review.

Authors:  Nahid S Awad; Vinod Paul; Nour M AlSawaftah; Gail Ter Haar; Theresa M Allen; William G Pitt; Ghaleb A Husseini
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-03

6.  Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration.

Authors:  Matthew Trendowski; Joan M Mitchell; Christine M Corsette; Christopher Acquafondata; Thomas P Fondy
Journal:  Invest New Drugs       Date:  2015-01-06       Impact factor: 3.850

7.  Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models.

Authors:  Matthew Trendowski; Joan M Mitchell; Christine M Corsette; Christopher Acquafondata; Thomas P Fondy
Journal:  Invest New Drugs       Date:  2015-01-07       Impact factor: 3.850

8.  Ultrasound Enhanced Anti-tumor Effect of Temozolomide in Glioblastoma Cells and Glioblastoma Mouse Model.

Authors:  Jie Xue; Yuanyuan Wu; Na Liu
Journal:  Cell Mol Bioeng       Date:  2018-09-06       Impact factor: 2.321

9.  Erythrocyte-Camouflaged Mesoporous Titanium Dioxide Nanoplatform for an Ultrasound-Mediated Sequential Therapies of Breast Cancer.

Authors:  Qunying Li; Bin Lin; Yongzhou Li; Nan Lu
Journal:  Int J Nanomedicine       Date:  2021-06-08

Review 10.  Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer.

Authors:  Gabrielle Wishart; Priyanka Gupta; Andrew Nisbet; Eirini Velliou; Giuseppe Schettino
Journal:  Cancers (Basel)       Date:  2021-06-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.